MediPharm Labs Corp. (OTCMKTS:MEDIF) Sees Significant Growth in Short Interest

MediPharm Labs Corp. (OTCMKTS:MEDIFGet Free Report) saw a significant increase in short interest in the month of June. As of June 30th, there was short interest totaling 341,209 shares, an increase of 382.8% from the June 15th total of 70,680 shares. Based on an average daily volume of 197,013 shares, the days-to-cover ratio is currently 1.7 days.

MediPharm Labs Price Performance

Shares of OTCMKTS:MEDIF opened at $0.05 on Tuesday. MediPharm Labs has a one year low of $0.04 and a one year high of $0.08. The company has a 50-day simple moving average of $0.06 and a 200-day simple moving average of $0.05.

MediPharm Labs Company Profile

(Get Free Report)

MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.

The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.

Featured Stories

Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.